JP2021152002A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021152002A5 JP2021152002A5 JP2021052571A JP2021052571A JP2021152002A5 JP 2021152002 A5 JP2021152002 A5 JP 2021152002A5 JP 2021052571 A JP2021052571 A JP 2021052571A JP 2021052571 A JP2021052571 A JP 2021052571A JP 2021152002 A5 JP2021152002 A5 JP 2021152002A5
- Authority
- JP
- Japan
- Prior art keywords
- hour
- administration
- obinutuzumab
- pharmaceutical composition
- cycle
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762574297P | 2017-10-19 | 2017-10-19 | |
| US62/574,297 | 2017-10-19 | ||
| JP2019508989A JP6860652B2 (ja) | 2017-10-19 | 2018-10-19 | 医薬組成物 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019508989A Division JP6860652B2 (ja) | 2017-10-19 | 2018-10-19 | 医薬組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021152002A JP2021152002A (ja) | 2021-09-30 |
| JP2021152002A5 true JP2021152002A5 (cg-RX-API-DMAC10.html) | 2021-12-02 |
| JP7370357B2 JP7370357B2 (ja) | 2023-10-27 |
Family
ID=64362606
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019508989A Active JP6860652B2 (ja) | 2017-10-19 | 2018-10-19 | 医薬組成物 |
| JP2021052571A Active JP7370357B2 (ja) | 2017-10-19 | 2021-03-26 | 医薬組成物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019508989A Active JP6860652B2 (ja) | 2017-10-19 | 2018-10-19 | 医薬組成物 |
Country Status (14)
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL3697818T3 (pl) * | 2017-10-19 | 2025-03-24 | F. Hoffmann-La Roche Ag | Leczenie CD20-dodatniego chłoniaka z limfocytów B obinutuzumabem |
| AU2020356896B2 (en) * | 2019-10-04 | 2026-07-30 | Chugai Seiyaku Kabushiki Kaisha | Inhibitor of cell proliferation in obinutuzumab resistant CD20-positive cancer, and medicinal composition, medicine, production, method for inhibiting cell proliferation, therapeutic method, type II anti-CD20 antibody, compounds, combination of same, enhancer and inducer, each relating thereto |
| WO2023042679A1 (ja) | 2021-09-17 | 2023-03-23 | キヤノン株式会社 | 送電装置および受電装置 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUE038955T2 (hu) | 2003-11-05 | 2018-12-28 | Roche Glycart Ag | Antigén-kötõ molekulák fokozott Fc receptor-kötõ affinitással és effektor funkcióval |
| WO2009080541A1 (en) | 2007-12-21 | 2009-07-02 | F. Hoffmann-La Roche Ag | Antibody formulation |
| RS63364B1 (sr) | 2014-08-11 | 2022-07-29 | Acerta Pharma Bv | Terapeutske kombinacije btk inhibitora, pd-1 inhibitora i/ili pd-l1 inhibitora |
| US11149091B2 (en) * | 2015-12-09 | 2021-10-19 | Cedars-Sinai Medical Center | Methods for treating nephrotic syndrome |
| CN108395482B (zh) * | 2017-02-08 | 2021-02-05 | 西比曼生物科技（香港）有限公司 | 一种靶向cd20抗原嵌合抗原受体的构建及其工程化t细胞的活性鉴定 |
| US12377681B2 (en) | 2017-07-21 | 2025-08-05 | The Yokohama Rubber Co., Ltd. | Pneumatic tire |
| PL3697818T3 (pl) * | 2017-10-19 | 2025-03-24 | F. Hoffmann-La Roche Ag | Leczenie CD20-dodatniego chłoniaka z limfocytów B obinutuzumabem |
-
2018
- 2018-10-19 PL PL18804720.3T patent/PL3697818T3/pl unknown
- 2018-10-19 ES ES18804720T patent/ES3005784T3/es active Active
- 2018-10-19 BR BR112020007731-3A patent/BR112020007731A2/pt unknown
- 2018-10-19 IL IL273909A patent/IL273909B2/en unknown
- 2018-10-19 TW TW112120572A patent/TWI828593B/zh active
- 2018-10-19 WO PCT/JP2018/038924 patent/WO2019017499A2/en not_active Ceased
- 2018-10-19 MX MX2020003418A patent/MX419643B/es unknown
- 2018-10-19 EP EP18804720.3A patent/EP3697818B1/en active Active
- 2018-10-19 CN CN201880067120.XA patent/CN111212854A/zh not_active Withdrawn
- 2018-10-19 CN CN202511095071.9A patent/CN120983618A/zh active Pending
- 2018-10-19 AU AU2018303836A patent/AU2018303836B2/en active Active
- 2018-10-19 CA CA3079374A patent/CA3079374A1/en active Pending
- 2018-10-19 JP JP2019508989A patent/JP6860652B2/ja active Active
- 2018-10-19 KR KR1020257043253A patent/KR20260011191A/ko active Pending
- 2018-10-19 KR KR1020207014191A patent/KR102766089B1/ko active Active
- 2018-10-19 US US16/756,057 patent/US12129304B2/en active Active
- 2018-10-19 TW TW107137033A patent/TWI805630B/zh active
- 2018-10-19 EP EP24213649.7A patent/EP4520347A3/en active Pending
- 2018-10-19 IL IL321935A patent/IL321935A/en unknown
- 2018-10-19 KR KR1020247035575A patent/KR102906969B1/ko active Active
-
2020
- 2020-07-13 MX MX2024009217A patent/MX2024009217A/es unknown
-
2021
- 2021-03-26 JP JP2021052571A patent/JP7370357B2/ja active Active
-
2024
- 2024-09-23 US US18/893,101 patent/US20250026847A1/en active Pending
-
2025
- 2025-07-15 AU AU2025205481A patent/AU2025205481A1/en active Pending